Oral contraceptive use before and after the latest pill scare in the Netherlands: Changes in oral contraceptive use and how users change

Contraception

Volumn 57, Issue 4, 1998, Pages 247-249

  De Vries, C S ^a   Van Den Berg, P B ^a   De Jong Van Den Berg, L T W ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Oral contraceptives; Pill scare; Prescribing behavior; Third generation progestagens

Indexed keywords

GESTAGEN; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; MEDICAL PRACTICE; NORMAL HUMAN; ORAL CONTRACEPTION; PRESCRIPTION;

EID: 0031840849     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(98)00021-3     Document Type: Article

References (7)

1. Carnall D., Karo H., Gunnar Lie L., et al. Third generation oral contraceptives - the controversy. Br Med J. 311:1995;1589-1590.
2. Jick H., Jick S.S., Gurewich V., Wald Myers M., Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet. 346:1995;1589-1593.
3. Spitzer W.O., Lewis M.A., Heinemann L.A.J., Thorogood M., MacRae K.D. Third generation oral contraceptives and risk of venous thromboembolic disorders an international case-control study . Br Med J. 312:1996;83-88.
4. Rosing J., Tans G., Nicolaes G.A.F., Thomassen M.C.L.G.D., Van Oerle R., Van der Ploeg P.M.E.N. Oral contraceptives and venous thrombosis different sensitivities to activated protein C in women using second- and third-generation oral contraceptives . Br J Heamatol. 97:1997;233-238.
5. Bloemenkamp K.W.M., Rosendaal F.R., Helmerhorst F.M., Büller H.R., Vandenbroucke J.P. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third generation progestagen. Lancet. 346:1995;1593-1596.
6. Ferguson J., Jenkins M.G. Effect of CSM's warnings about safety of third generation oral contraceptive general practitioners in England prescribed second generation pills instead [letter] . Br Med J. 313:1996;363.
7. Iversen O.E., Nilsen S.T. Effect of CSM's warnings about safety of third generation oral contraceptive abortions increased by nearly 8% in Norway [letter] . Br Med J. 313:1996;363-364.